BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.79B
AUM Growth
-$8.56B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$159M
2
+$98.3M
3
+$70.5M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$67.8M
5
REPL icon
Replimune Group
REPL
+$41.9M

Top Sells

1
+$9.45B
2
+$337M
3
+$198M
4
SWTX
SpringWorks Therapeutics
SWTX
+$69.4M
5
ROIV icon
Roivant Sciences
ROIV
+$48.1M

Sector Composition

1 Healthcare 98.37%
2 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$40.1M 0.46%
3,882,125
27
$38M 0.43%
48,015
-8,084
28
$37.8M 0.43%
1,062,123
29
$34.1M 0.39%
3,112,786
+2,063,087
30
$32.5M 0.37%
5,434,399
+3,919,057
31
$32.4M 0.37%
1,790,390
+946,576
32
$30.7M 0.35%
3,691,011
+533,247
33
$30.6M 0.35%
2,108,949
34
$27.8M 0.32%
4,916,095
35
$23.6M 0.27%
1,691,530
+275,000
36
$21.1M 0.24%
169,934
37
$20.9M 0.24%
2,080,000
+1,080,000
38
$17.9M 0.2%
425,009
39
$16.2M 0.18%
2,784,792
40
$14.6M 0.17%
1,000,000
41
$13.9M 0.16%
1,461,426
42
$12.8M 0.15%
1,160,117
43
$11M 0.13%
2,006,451
44
$10.7M 0.12%
2,030,134
+544,219
45
$10.7M 0.12%
2,497,526
46
$10.6M 0.12%
343,000
47
$9.82M 0.11%
+247,644
48
$9.11M 0.1%
1,028,466
49
$8.79M 0.1%
453,516
+148,162
50
$8.7M 0.1%
10,969,282
1
2
3 4 5